SEC Form 3 · accession 0001670000-26-000007
Whitehawk Therapeutics, Inc. · WHWK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Vijay K Iyengar
Director
Period of report
Sep 9, 2026
Accepted (ET)
Sep 11, 2026 · 4:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001422142
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
No Table II lines on this filing.
Remarks
Exhibit 24 - Power of Attorney